NEW ORLEANS —Adolescents with new-onset type 2 diabetes and obesity were more likely to achieve an HbA1c of less than 6% at 1 year with sleeve gastrectomy compared with treat-to-target medical therapy, researchers reported. Amy S. Shah, MD, MS, FNLA, director of the division of endocrinology at Cincinnati Children’s Hospital, said the SURPASS-PEDS trial showed tirzepatide